Stock BCAB BIOATLA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart BioAtla, Inc.

Equities

BCAB

US09077B1044

Market Closed - Nasdaq
Other stock markets
 01:30:00 15/05/2024 am IST 		5-day change 1st Jan Change
2.61 USD -1.14% Intraday chart for BioAtla, Inc. -15.53% +6.10%
06/05 BioAtla's Multiple Cancer Drug Candidate Receives FDA Clearance MT
06/05 BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3361, a CAB-Nectin-4 Antibody Drug Conjugate for the Treatment of Multiple Tumors CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
BIOATLA, INC. Stock BioAtla, Inc.
 127M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 48.16B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 41.73B
LONZA GROUP AG Stock Lonza Group AG
 41.03B
CELLTRION, INC. Stock Celltrion, Inc.
 28.77B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 25.59B
  1. Stock Market
  2. Equities
  3. BCAB Stock
  4. Charts BioAtla, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW